Kao, Roy L <br/><br/>
A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy.  [electronic resource] 

 -  Human gene therapy  04 2019 
 - 413-428 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-7422 
<br/><br/><label>Standard No.: </label>10.1089/hum.2018.180  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibody-Dependent Cell Cytotoxicity--genetics<br/>Antigens, CD19--genetics<br/>Antineoplastic Agents, Immunological--pharmacology<br/>Cell Line, Tumor<br/>Cetuximab--pharmacology<br/>Combined Modality Therapy<br/>Complement System Proteins--immunology<br/>Cytotoxicity, Immunologic<br/>Disease Models, Animal<br/>Gene Expression Regulation<br/>Genes, Reporter<br/>Genetic Therapy--methods<br/>Genetic Vectors--genetics<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Hematopoietic Stem Cells--immunology<br/>Humans<br/>Immunotherapy<br/>Lentivirus--genetics<br/>Mice<br/>Mice, Transgenic<br/>Neoplasms--genetics<br/>Positron-Emission Tomography<br/>Receptors, Chimeric Antigen--genetics<br/>Transduction, Genetic<br/>Xenograft Model Antitumor Assays